Dufies, M., Giuliano, S., Viotti, J., Borchiellini, D., Cooley, L. S., Ambrosetti, D., . . . Pagès, G. (2017). CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas. Br J Cancer.
シカゴスタイル引用形Dufies, Maeva, et al. "CXCL7 Is a Predictive Marker of Sunitinib Efficacy in Clear Cell Renal Cell Carcinomas." Br J Cancer 2017.
MLA引用形式Dufies, Maeva, et al. "CXCL7 Is a Predictive Marker of Sunitinib Efficacy in Clear Cell Renal Cell Carcinomas." Br J Cancer 2017.
警告: この引用は必ずしも正確ではありません.